PureCycle Technologies, Inc. (PCT) Insider Trading

Last 12 months

Insiders bought $99k on the open market and sold nothing.

Net open-market

+$99k

1 buy · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Sep 2026

Sep 4, 2026

Get an email when PCT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 4	Fernando Musa Director	Bought	15,479	$6.38	$99k	9.6%	Form 4
May 12	Sylebra Capital LLC Large holder	Bought	16,622	—	—	<0.1%	Form 4
Feb 6, 2025	Sylebra Capital LLC Large holder	Bought	619,925	$8.06	$5M	1.9%	Form 4

Sep 4
Fernando Musa
Director · bought 15,479 at $6.38
$99k
9.6% of stake
May 12
Sylebra Capital LLC
Large holder · bought 16,622
—
<0.1% of stake
Feb 6, 2025
Sylebra Capital LLC
Large holder · bought 619,925 at $8.06
$5M
1.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PCT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Plastic Materials, Synth Resins & Nonvulcan Elastomers

JANXJanux Therapeutics Inc.

PYXSPyxis Oncology, Inc.

ORGNOrigin Materials Inc.

CRSPCrispr Therapeutics AG

CVSICV Sciences, Inc.

EVMNEvommune, Inc.

KROSKeros Therapeutics Inc.

LCTXLineage Cell Therapeutics Inc.

Spot a number that looks wrong? Check it in PCT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PCT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.